SI-BONE Inc

NASDAQ:SIBNUnited States

SI-BONE, Inc. is a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy. The Company specializes in minimally invasive surgical implant systems to address sacroiliac joint dysfunction as well as address unmet clinical needs in pelvic fixation and management of pelvic fractures. The Company's products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products. Its products include iFuse, iFuse-3D, iFuse-TORQ and iFuse Bedrock Granite. Within the United States, iFuse, iFuse-3D and iFuse-TORQ have clearances for applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma. Its first-generation iFuse, a machined triangular titanium implant, has a triangular cross section that resists twisting or rotation of the implant. The Company's second generation iFuse product, the iFuse-3D implant, is a patented titanium implant.

Contact Information

Headquarters

471 El Camino Real, Suite 101SANTA CLARA, CA, United States 95050

Phone

408-207-0700

Fax

408-557-8312

Executives

Executive Chairman of the Board

Jeffrey Dunn

Chief Executive Officer, Director

Laura Francis

Chief Financial Officer

Anshul Maheshwari

President - Commercial Operations

Anthony Recupero

General Counsel, Company Secretary

Michael Pisetsky